Alcohol withdrawal syndrome (AWS) is a potentially life-threatening condition that may complicate patients’ recovery after surgery.This article was originally published on MedicalXpress.com
A new data analysis, published in Vaccine has found that women and menstruating people who had one or more mRNA-based COVID-19 vaccinations were more likely to experience changes to their menstrual cycle in the six […]
The blood pressure-lowering effect of nitrate-rich beetroot juice in older people may be due to specific changes in their oral microbiome, according to the largest study of its kind.This article was originally published on MedicalXpress.com
Roughly 1 in 10 babies worldwide is born before 37 weeks of pregnancy—a birth considered preterm. These infants are biologically less mature at birth and face a higher risk of developmental delays in various domains. […]
A groundbreaking brain imaging study from Wake Forest University School of Medicine confirms a vital step toward new Alzheimer’s disease treatments: Intranasal insulin, delivered via a simple nasal spray, safely and effectively reaches key memory […]
More accurate measures are needed to help diagnose children with sepsis as a current clinical tool is failing to detect those requiring hospital care, according to a new study.This article was originally published on MedicalXpress.com
Pharmaceutical scientists, clinicians, nurses and pharmacists from the National University of Singapore (NUS) and National University Hospital (NUH) have shown that a reduced dose of abiraterone acetate is potentially as effective and safe as the […]
People with any type of substance use disorder (SUD) stand a 24% higher risk of having an unplanned hospital readmission within 30 days of a previous discharge compared with those without the disorder, new UCLA-led […]
GLP-1 receptor agonists, a class of drug used to treat type 2 diabetes, likely trump the widely prescribed metformin for curbing dementia risk in people with the condition, finds the largest study of its kind, […]
For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for dementia, stroke, and all-cause mortality compared with other antidiabetic drugs, according to a […]
© 2025 SimplyWell.ca